Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study

  • Alessandra Pulvirenti
  • , Georgios A. Margonis
  • , Vicente Morales-Oyarvide
  • , Caitlin A. McIntyre
  • , Sharon A. Lawrence
  • , Debra A. Goldman
  • , Mithat Gonen
  • , Matthew J. Weiss
  • , Cristina R. Ferrone
  • , Jin He
  • , Murray F. Brennan
  • , John L. Cameron
  • , Keith D. Lillemoe
  • , T. Peter Kingham
  • , Vinod Balachandran
  • , Motaz Qadan
  • , Michael I. D'Angelica
  • , William R. Jarnagin
  • , Christopher L. Wolfgang
  • , Carlos Fernández Del Castillo
  • Peter J. Allen

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Objective:To evaluate the influence of consensus guidelines on the management of intraductal papillary mucinous neoplasms (IPMN) and the subsequent changes in pathologic outcomes.Background:Over time, multiple guidelines have been developed to identify high-risk IPMN. We hypothesized that the development and implementation of guidelines should have increased the percentage of resected IPMN with high-risk disease.Methods:Memorial Sloan-Kettering (MSK), Johns Hopkins (JH), and Massachusetts General Hospital (MGH) databases were queried for resected IPMN (2000-2015). Patients were categorized into main-duct (MD-IPMN) versus branch-duct (BD-IPMN). Guideline-specific radiographic/endoscopic features were recorded. High-risk disease was defined as high-grade dysplasia/carcinoma. Fisher's exact test was used to detect differences between institutions. Logistic regression evaluated differences between time-points [preguidelines (pre-GL, before 2006), Sendai (SCG, 2006-2012), Fukuoka (FCG, after 2012)].Results:The study included 1210 patients. The percentage of BD-IPMN with ≥1 high-risk radiographic feature differed between centers (MSK 69%, JH 60%, MGH 45%; P < 0.001). In MD-IPMN cohort, the presence of radiographic features such as solid component and main pancreatic duct diameter ≥10 mm also differed (solid component: MSK 38%, JH 30%, MGH 18%; P < 0.001; duct ≥10 mm: MSK 49%, JH 32%, MGH 44%; P < 0.001). The percentage of high-risk disease on pathology, however, was similar between institutions (BD-IPMN: P = 0.36, MD-IPMN: P = 0.48). During the study period, the percentage of BD-IPMN resected with ≥1 high-risk feature increased (52% pre-GL vs 67% FCG; P = 0.005), whereas the percentage of high-risk disease decreased (pre-GL vs FCG: 30% vs 20%). For MD-IPMN, there was not a clear trend towards guideline adherence, and the rate of high-risk disease was similar over the time (pre-GL vs FCG: 69% vs 67%; P = 0.63).Conclusion:Surgical management of IPMN based on radiographic criteria is variable between institutions, with similar percentages of high-risk disease. Over the 15-year study period, the rate of BD-IPMN resected with high-risk radiographic features increased; however, the rate of high-risk disease decreased. Better predictors are needed.

Original languageEnglish (US)
Pages (from-to)E980-E987
JournalAnnals of surgery
Volume274
Issue number6
DOIs
StatePublished - Dec 1 2021
Externally publishedYes

Keywords

  • IPMN
  • cancer
  • dysplasia
  • guidelines
  • intraductal papillary mucinous neoplasm
  • pancreas
  • pancreatic surgery consortium
  • radiographic features

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study'. Together they form a unique fingerprint.

Cite this